BillionToOne, Inc. (BLLN) Stock

Healthcare · Diagnostics & Research · Member of Other US Stocks

BillionToOne, Inc. (BLLN) closed at USD 97.88 on 2026-10-14, a change of -10.2 % over the past year, with a market capitalization of USD 4.85B.

BillionToOne, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

BillionToOne, Inc. key figures

Previous close

USD 97.88 (2026-10-14)

1-year change

-10.2 %

Market cap

USD 4.85B

Enterprise value

USD 4.44B

P/E ratio (trailing)

163.06

P/E ratio (forward)

69.18

EPS (trailing)

0.63

EPS (forward)

1.49

PEG ratio

n/a

Price to book

8.96

Revenue growth

64.4 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

4.40

Employees

713

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About BillionToOne, Inc.

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for BillionToOne, Inc. and compare it with other stocks.